| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 114.2 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 114.2. The average price that BIM.PA shares were previous bought at was EUR 108.661. The current market price is 5.1% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 13,985 (USD $15,841) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 42.45 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 42.45. The average price that FME.DE shares were previous bought at was EUR 44.2419. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 35,282 (USD $39,965) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 56.9267 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 56.9267. The average price that ZEAL.CO shares were previous bought at was DKK 81.219. The current market price is -29.9% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 78,473 (USD $11,906) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 54.22 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 54.22. The average price that ERF.PA shares were previous bought at was EUR 49.0647. The current market price is 10.5% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 68,002 (USD $77,028) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 229.9 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 229.9. The average price that SRT3.DE shares were previous bought at was EUR 221.961. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 1,245 (USD $1,410) compared to the previous valuation of Sartorius AG |
| SOBI.ST - | HOLD | 0 @ SEK 25.2806 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 25.2806. The average price that SOBI.ST shares were previous bought at was SEK 26.8142. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 12,542 (USD $1,295) compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 95.7021 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 95.7021. The average price that GALD.SW shares were previous bought at was CHF 96.9381. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 450,639 (USD $543,069) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 201.3 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 201.3. The average price that DIM.PA shares were previous bought at was EUR 187.837. The current market price is 7.2% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 49.22 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 49.22. The average price that REC.MI shares were previous bought at was EUR 52.5394. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 13,200 (USD $14,952) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 53.55 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 53.55. The average price that ORNBV.HE shares were previous bought at was EUR 47.9545. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 175,052 (USD $198,287) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 297.527 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 297.527. The average price that RO.SW shares were previous bought at was CHF 304.565. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 58,885 (USD $70,963) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 98.35 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 98.35. The average price that IPN.PA shares were previous bought at was EUR 108.377. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 65,857 (USD $74,598) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 22.5001 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 22.5001. The average price that HIK.L shares were previous bought at was GBP 24.382. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 18,478 (USD $24,510) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 30.9146 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 30.9146. The average price that DEMANT.CO shares were previous bought at was DKK 34.3207. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 252 (USD $38) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.448 | EUR 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 17.05 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 17.05. The average price that AMP.MI shares were previous bought at was EUR 23.0876. The current market price is -26.2% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 7,795 (USD $8,830) compared to the previous valuation of Amplifon SpA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 54.931 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 54.931. The average price that NOVO-B.CO shares were previous bought at was DKK 69.9097. The current market price is -21.4% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 261,717 (USD $39,708) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 95.7441 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 95.7441. The average price that COLO-B.CO shares were previous bought at was DKK 98.8373. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 16,558 (USD $2,512) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 37.61 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 37.61. The average price that QIA.DE shares were previous bought at was EUR 36.5924. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 6,686 (USD $7,573) compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.4087 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.4087. The average price that HLN.L shares were previous bought at was GBP 4.66661. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 182,492 (USD $242,067) compared to the previous valuation of Haleon PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 22.48 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 22.48. The average price that BAYN.DE shares were previous bought at was EUR 21.0708. The current market price is 6.7% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 174,859 (USD $198,069) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 97.8289 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 97.8289. The average price that NOVN.SW shares were previous bought at was CHF 97.7507. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 1,049,198 (USD $1,264,399) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 122.264 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 122.264. The average price that AZN.L shares were previous bought at was GBP 129.901. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 793,735 (USD $1,052,853) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 93.35 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 93.35. The average price that SAN.PA shares were previous bought at was EUR 97.4161. The current market price is -4.2% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 59,349 (USD $67,227) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 16.319 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 16.319. The average price that GSK.L shares were previous bought at was GBP 16.7052. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 376,511 (USD $499,424) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 252 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 252. The average price that EL.PA shares were previous bought at was EUR 249.877. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 748,069 (USD $847,363) compared to the previous valuation of EssilorLuxottica SA |
| LONN.SW - | HOLD | 0 @ CHF 602.923 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 602.923. The average price that LONN.SW shares were previous bought at was CHF 575.623. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 172,149 (USD $207,458) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 82.5165 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 82.5165. The average price that ALC.SW shares were previous bought at was CHF 82.6482. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 95,524 (USD $115,117) compared to the previous valuation of |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 531.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 531.6. The average price that ARGX.BR shares were previous bought at was EUR 572.549. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 114,636 (USD $129,852) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 147.35 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 147.35. The average price that UCB.BR shares were previous bought at was EUR 176.904. The current market price is -16.7% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 36,010 (USD $40,790) compared to the previous valuation of UCB SA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 278.919 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 278.919. The average price that ROG.SW shares were previous bought at was CHF 287.977. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,443,755 (USD $1,739,883) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 21.66 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 21.66. The average price that PHIA.AS shares were previous bought at was EUR 24.0301. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 15,167 (USD $17,180) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 119.75 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 119.75. The average price that MRK.DE shares were previous bought at was EUR 134.996. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 52,132 (USD $59,052) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 35.9734 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 35.9734. The average price that SDZ.SW shares were previous bought at was CHF 39.4518. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 114,654 (USD $138,171) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 264.351 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 264.351. The average price that SOON.SW shares were previous bought at was CHF 298.317. The current market price is -11.4% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 173,499 (USD $209,085) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 45.88 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 45.88. The average price that SHL.DE shares were previous bought at was EUR 50.8815. The current market price is -9.8% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 33,286 (USD $37,704) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 39.85 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 39.85. The average price that FRE.DE shares were previous bought at was EUR 35.9767. The current market price is 10.8% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 74,185 (USD $84,032) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 179.487 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 179.487. The average price that GMAB.CO shares were previous bought at was DKK 194.212. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 41,081 (USD $6,233) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 107.612 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 107.612. The average price that STMN.SW shares were previous bought at was CHF 119.697. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 79,512 (USD $95,821) compared to the previous valuation of however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.7593 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.7593. The average price that SN.L shares were previous bought at was GBP 12.7655. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in SN.L has increased by GBP 11,473 (USD $15,218) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-04-24 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | SELL | -740 @ EUR 99.5 | EUR -73,630 | The ETF sold 740 shares of DIA.MI on 2025-04-24. The shares were previously bought for an average price of EUR 64.2316. The DiaSorin SpA shares were sold for 54.9% higher than average price of previous purchases. This sale made a profit of EUR 26,099 (USD $29,563) The average price that the ETF previously sold DIA.MI share for is EUR 98.7882 so the ETF has sold 740 shares on 2025-04-24 at a higher price than the previous selling average. |